Half-year report · HY
4937.TEDINET S100Y3R1
Period2025-10-01 → 2026-03-31
Filed2026-05-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥1.1bn | 2025-10-01 → 2026-03-31 | Cons. | Net sales |
| Revenue | ¥2.0bn | 2024-10-01 → 2025-09-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥835m | 2024-10-01 → 2025-03-31 | Cons. | Net sales |
| Operating income | ¥138m | 2025-10-01 → 2026-03-31 | Cons. | Operating income |
| Operating income | −¥52m | 2024-10-01 → 2025-03-31 | Cons. | Operating income |
| Ordinary income | ¥135m | 2025-10-01 → 2026-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥152m | 2024-10-01 → 2025-09-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | −¥55m | 2024-10-01 → 2025-03-31 | Cons. | Ordinary income |
| Profit before tax | ¥135m | 2025-10-01 → 2026-03-31 | Cons. | Income before income taxes |
| Profit before tax | −¥55m | 2024-10-01 → 2025-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥136m | 2025-10-01 → 2026-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥44m | 2024-10-01 → 2025-09-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥59m | 2024-10-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥136m | 2025-10-01 → 2026-03-31 | Cons. | Profit loss |
| Net income | −¥59m | 2024-10-01 → 2025-03-31 | Cons. | Profit loss |
| Total assets | ¥3.4bn | at 2026-03-31 | Cons. | Assets |
| Total assets | ¥3.2bn | at 2025-09-30 | Cons. | Assets |
| Total assets | ¥3.0bn | at 2025-03-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥1.2bn | at 2026-03-31 | Cons. | Liabilities |
| Total liabilities | ¥1.1bn | at 2025-09-30 | Cons. | Liabilities |
| Net assets / equity | ¥2.2bn | at 2026-03-31 | Cons. | Net assets |
| Net assets / equity | ¥2.1bn | at 2025-09-30 | Cons. | Net assets |
| Net assets / equity | ¥2.1bn | at 2025-03-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥1.4bn | at 2026-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥1.3bn | at 2025-09-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥1.4bn | at 2026-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.3bn | at 2025-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.3bn | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.5bn | at 2024-09-30v | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥163m | 2025-10-01 → 2026-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥136m | 2024-10-01 → 2025-09-30 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥10m | 2024-10-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥4m | 2025-10-01 → 2026-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥189m | 2024-10-01 → 2025-09-30 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥88m | 2024-10-01 → 2025-03-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥92m | 2025-10-01 → 2026-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥150m | 2024-10-01 → 2025-09-30 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥123m | 2024-10-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥38.63 | 2025-10-01 → 2026-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥12.32 | 2024-10-01 → 2025-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-16.36 | 2024-10-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥38.41 | 2025-10-01 → 2026-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥12.24 | 2024-10-01 → 2025-09-30 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 65.6% | at 2026-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 65.1% | at 2025-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 67.9% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 34
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2025-10-01 → 2026-03-31 | ¥126m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2025-10-01 → 2026-03-31 | ¥126m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2025-10-01 → 2026-03-31 | ¥95m |
| Reconciling Itemsreconciling | revenue | 2025-10-01 → 2026-03-31 | −¥539,000 |
| Reconciling Itemsreconciling | revenue intersegment | 2025-10-01 → 2026-03-31 | −¥539,000 |
| Reconciling Itemsreconciling | segment profit | 2025-10-01 → 2026-03-31 | −¥208m |
| Direct To Consumer Businessreportable segment | revenue | 2025-10-01 → 2026-03-31 | ¥376m |
| Direct To Consumer Businessreportable segment | revenue external | 2025-10-01 → 2026-03-31 | ¥376m |
| Direct To Consumer Businessreportable segment | segment profit | 2025-10-01 → 2026-03-31 | ¥163m |
| Medical Supportreportable segment | revenue | 2025-10-01 → 2026-03-31 | ¥632m |
| Medical Supportreportable segment | revenue external | 2025-10-01 → 2026-03-31 | ¥632m |
| Medical Supportreportable segment | revenue intersegment | 2025-10-01 → 2026-03-31 | ¥539,000 |
| Medical Supportreportable segment | segment profit | 2025-10-01 → 2026-03-31 | ¥88m |
| —segment total | revenue | 2025-10-01 → 2026-03-31 | ¥1.0bn |
| —segment total | revenue external | 2025-10-01 → 2026-03-31 | ¥1.0bn |
| —segment total | revenue intersegment | 2025-10-01 → 2026-03-31 | ¥539,000 |
| —segment total | segment profit | 2025-10-01 → 2026-03-31 | ¥251m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2025-10-01 → 2026-03-31 | ¥1.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2025-10-01 → 2026-03-31 | ¥1.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2025-10-01 → 2026-03-31 | ¥539,000 |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2025-10-01 → 2026-03-31 | ¥346m |
| Reconciling Itemsreconciling | segment profit | 2024-10-01 → 2025-03-31 | −¥187m |
| Direct To Consumer Businessreportable segment | revenue | 2024-10-01 → 2025-03-31 | ¥503m |
| Direct To Consumer Businessreportable segment | revenue external | 2024-10-01 → 2025-03-31 | ¥503m |
| Direct To Consumer Businessreportable segment | segment profit | 2024-10-01 → 2025-03-31 | ¥144m |
| Medical Supportreportable segment | revenue | 2024-10-01 → 2025-03-31 | ¥332m |
| Medical Supportreportable segment | revenue external | 2024-10-01 → 2025-03-31 | ¥332m |
| Medical Supportreportable segment | segment profit | 2024-10-01 → 2025-03-31 | −¥9m |
| —segment total | revenue | 2024-10-01 → 2025-03-31 | ¥835m |
| —segment total | revenue external | 2024-10-01 → 2025-03-31 | ¥835m |
| —segment total | segment profit | 2024-10-01 → 2025-03-31 | ¥135m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-10-01 → 2025-03-31 | ¥835m |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-10-01 → 2025-03-31 | ¥835m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-10-01 → 2025-03-31 | ¥135m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 455
| Item | Context | Value | Unit |
|---|---|---|---|
| Transactions with other segments | Prior1InterimDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | － | JPY |
| Transactions with other segments | Prior1InterimDuration_TotalOfReportableSegmentsAndOthersMember | － | JPY |
| Transactions with other segments | Prior1InterimDuration_ReconcilingItemsMember | － | JPY |
| Transactions with other segments | Prior1InterimDuration | － | JPY |
| Net sales | Prior1InterimDuration_jpcrp040300-ssr_E36697-000MedicalSupportReportableSegmentMember | 331854000 | JPY |
| Net sales | Prior1InterimDuration_jpcrp040300-ssr_E36697-000DirectToConsumerBusinessReportableSegmentMember | 502999000 | JPY |
| Net sales | Prior1InterimDuration_ReportableSegmentsMember | 834854000 | JPY |
| Net sales | Prior1InterimDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | － | JPY |
| Net sales | Prior1InterimDuration_TotalOfReportableSegmentsAndOthersMember | 834854000 | JPY |
| Net sales | Prior1InterimDuration_ReconcilingItemsMember | － | JPY |
| Net sales | Prior1InterimDuration | 834854000 | JPY |
| Operating income | Prior1InterimDuration_jpcrp040300-ssr_E36697-000MedicalSupportReportableSegmentMember | -8594000 | JPY |
| Operating income | Prior1InterimDuration_jpcrp040300-ssr_E36697-000DirectToConsumerBusinessReportableSegmentMember | 143573000 | JPY |
| Operating income | Prior1InterimDuration_ReportableSegmentsMember | 134978000 | JPY |
| Operating income | Prior1InterimDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | － | JPY |
| Operating income | Prior1InterimDuration_TotalOfReportableSegmentsAndOthersMember | 134978000 | JPY |
| Operating income | Prior1InterimDuration_ReconcilingItemsMember | -187283000 | JPY |
| Operating income | Prior1InterimDuration | -52305000 | JPY |
| Revenues from external customers | InterimDuration_jpcrp040300-ssr_E36697-000MedicalSupportReportableSegmentMember | 631890000 | JPY |
| Revenues from external customers | InterimDuration_jpcrp040300-ssr_E36697-000DirectToConsumerBusinessReportableSegmentMember | 376022000 | JPY |
| Revenues from external customers | InterimDuration_ReportableSegmentsMember | 1007912000 | JPY |
| Revenues from external customers | InterimDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 125560000 | JPY |
| Revenues from external customers | InterimDuration_TotalOfReportableSegmentsAndOthersMember | 1133473000 | JPY |
| Revenues from external customers | InterimDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | InterimDuration | 1133473000 | JPY |
| Transactions with other segments | InterimDuration_jpcrp040300-ssr_E36697-000MedicalSupportReportableSegmentMember | 539000 | JPY |
| Transactions with other segments | InterimDuration_jpcrp040300-ssr_E36697-000DirectToConsumerBusinessReportableSegmentMember | － | JPY |
| Transactions with other segments | InterimDuration_ReportableSegmentsMember | 539000 | JPY |
| Transactions with other segments | InterimDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | － | JPY |
| Transactions with other segments | InterimDuration_TotalOfReportableSegmentsAndOthersMember | 539000 | JPY |
| Transactions with other segments | InterimDuration_ReconcilingItemsMember | -539000 | JPY |
| Transactions with other segments | InterimDuration | － | JPY |
| Net sales | InterimDuration_jpcrp040300-ssr_E36697-000MedicalSupportReportableSegmentMember | 632429000 | JPY |
| Net sales | InterimDuration_jpcrp040300-ssr_E36697-000DirectToConsumerBusinessReportableSegmentMember | 376022000 | JPY |
| Net sales | InterimDuration_ReportableSegmentsMember | 1008451000 | JPY |
| Net sales | InterimDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 125560000 | JPY |
| Net sales | InterimDuration_TotalOfReportableSegmentsAndOthersMember | 1134012000 | JPY |
| Net sales | InterimDuration_ReconcilingItemsMember | -539000 | JPY |
| Net sales | InterimDuration | 1133473000 | JPY |
| Operating income | InterimDuration_jpcrp040300-ssr_E36697-000MedicalSupportReportableSegmentMember | 88122000 | JPY |
| Operating income | InterimDuration_jpcrp040300-ssr_E36697-000DirectToConsumerBusinessReportableSegmentMember | 162838000 | JPY |
| Operating income | InterimDuration_ReportableSegmentsMember | 250960000 | JPY |
| Operating income | InterimDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 95318000 | JPY |
| Operating income | InterimDuration_TotalOfReportableSegmentsAndOthersMember | 346279000 | JPY |
| Operating income | InterimDuration_ReconcilingItemsMember | -208108000 | JPY |
| Operating income | InterimDuration | 138170000 | JPY |
| Document title cover page | FilingDateInstant | Original text (Japanese)半期報告書 | |
| Clause of stipulation cover page | FilingDateInstant | Original text (Japanese)金融商品取引法第24条の５第１項の表の第１号 | |
| Place of filing cover page | FilingDateInstant | Original text (Japanese)関東財務局長 | |
| Filing date cover page | FilingDateInstant | 2026-05-14 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |